Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus Infections among young adult injection drug users

Drug and Alcohol Dependence

Volumn 91, Issue SUPPL. 1, 2007, Pages

  Purcell, David W ^a   Garfein, Richard S ^a   Latka, Mary H ^b   Thiede, Hanne ^c   Hudson, Sharon ^d   Bonner, Sebastian ^b   Golub, Elizabeth T ^e   Ouellet, Lawrence J ^f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c Public Health Seattle and King County   (United States)

^d Health Research Association   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Behavioral risk reduction; HCV prevention intervention; HIV prevention intervention; Injection drug use; Intervention development

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; GROUP DYNAMICS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTERVENTION STUDY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PEER GROUP; PRIORITY JOURNAL; QUALITY CONTROL; RISK REDUCTION; SEXUAL BEHAVIOR; THEORY;

ADOLESCENT; ADULT; COGNITIVE THERAPY; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HEALTH EDUCATION; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

HEPATITIS C VIRUS;

EID: 34548292647     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.03.004     Document Type: Article

References (45)

1. Alter M.J. Epidemiology of hepatitis C. Hepatology 26 (1997) 62S-65S
2. Bandura A. Social Foundations of Thought and Action (1986), Prentice Hall, Englewood Cliffs, NJ
3. Broadhead R.S., Heckathorn D.D., Weakliem D.L., Anthony D.L., Madray H., Mills R.J., and Hughes J. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 113 Suppl. 1 (1998) 42-57
4. Centers for Disease Control and Prevention, 2006. HIV/AIDS Surveillance Report, 2005. Vol. 17. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta. Also available at: http://www.cdc.gov/hiv/stats/hasrlink.htm (accessed on February 20, 2007).
5. Centers for Disease Control and Prevention, 1999. HIV/AIDS Prevention Research Synthesis Project. Compendium of HIV Prevention Interventions with Evidence of Effectiveness, Revised. Centers for Disease Control and Prevention, Atlanta. Also available at: http://www.cdc.gov/hiv/pubs/hivcompendium/HIVcompendium.pdf (accessed on February 20, 2007).
6. Coyle S.L., Needle R.H., and Normand J. Outreach-based HIV prevention for injecting drug users: A review of published outcome data. Public Health Rep. 113 Suppl. 1 (1998) 19-30
7. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Abdul-Quader A., Heckathorn D.D., McKnight C., Bramson H., Nemeth C., Torian L.V., and Friedman S.R. Convergence of HIV seroprevalance among injecting and non-injecting drug users in New York City. AIDS 21 (2007) 231-235
8. Des Jarlais D.C., Diaz T., Perlis T., Vlahov D., Maslow C., Latka M., Rockwell R., Edwards V., Friedman S.R., Monterroso E., Williams I., and Garfein R.S. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am. J. Epidemiol. 157 (2003) 467-471
9. Des Jarlais D.C., Perlis T., Arasteh K., Torian L.V., Hagan H., Beatrice S., Smith L., Wethers J., Milliken J., Mildvan D., Yancovitz S., and Friedman S.R. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS 19 Suppl. 3 (2005) S20-S25
10. Fisher J.D., and Fisher W.A. Changing AIDS-risk behavior. Psychol. Bull. 111 (1992) 455-474
11. Fisher J.D., and Misovich S. Social influence and AIDS-preventive behavior. In: Edwards J., Tindale R.S., Heath L., and Posavac E.J. (Eds). Social Influence Processes and Prevention (1990), Plenum Press, New York 39-70
12. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. 18 (1998) S11-S19
13. Garfein R.S., Vlahov D., Galai N., Doherty M.C., and Nelson K.E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Public Health 86 (1996) 655-661
14. Grund J.P., Kaplan C.D., Adriaans N.F., Blanken P., and Huisman J. The limitations of the concept of needle sharing: the practice of 'frontloading'. AIDS 4 (1990) 819-821
15. Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., and Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 91 (2001) 42-46
16. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., Busch M.P., Tobler L.H., Phelps B., and Moss A.R. Hepatitis C virus seroconversion among young injection drug users: relationship and risk. J. Infect. Dis. 186 (2002) 1558-1564
17. Kelly J.A., McAuliffe T.L., Sikkema K.J., Murphy D.A., Somlai A.M., Mulry G., Miller J.G., Stevenson L.Y., and Fernandez M.I. Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention. Psychiatr. Services 48 (1997) 1283-1288
18. Kelly J.A., St Lawrence J.S., Diaz Y.E., and Stevenson L.Y. HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. Am. J. Public Health 81 (1991) 168-171
19. Koester S., Glanz J., and Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 9 (2005) 27-39
20. Kotranski L., Semaan S., Collier K., Lauby J., Halbert J., and Feighan J. Effectiveness of an HIV risk reduction counseling intervention for out-of-treatment drug users. AIDS Educ. Prev. 10 (1998) 19-33
21. Kral A.H., Bluthenthal R.N., Lorvick J., Gee L., Bacchetti P., and Edlin B.R. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357 (2001) 1397-1401
22. Krathwohl D.R. A revision of Bloom's taxonomy: an overview. Theory Pract. 41 4 (2002) 212-218
23. Latka M., Ahern J., Garfein R.S., Ouellet L., Kerndt P., Morse P., Farshay C.E., Des Jarlais D.C., and Vlahov D. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J. Subst. Abuse 13 (2001) 73-88
24. Latkin C.A. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Rep. 113 Suppl. 1 (1998) 151-159
25. Latkin C.A., Sherman S., and Knowlton A. HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychol. 24 (2003) 332-339
26. McClusker J., Stoddard A.M., Zapka J.G., Morrison C.S., Zorn N., and Lewis B.F. AIDS education for drug users: evaluation of short-term effectiveness. Am. J. Public Health 82 (1992) 533-540
27. McMahon R.C., Malow R.M., Jennings T.E., and Gomez C.J. Effects of a cognitive-behavioral HIV prevention intervention among HIV negative male substance abusers in VA residential treatment. AIDS Educ. Prev. 13 (2001) 91-107
28. Miller L., Murphy S., Clark L., Hamburger M., and Moore J. Hierarchical messages for introducing multiple prevention options: Promise and pitfalls. AIDS Educ. Prev. 16 (2005) 509-525
29. Nelson K.E., Vlahov D., Solomon L., Cohn S., and Muñoz A. Temporal trends of incident HIV infection in a cohort of injection drug users in Baltimore, Maryland. Arch. Intern. Med. 155 (1995) 1305-1311
30. Nicolosi A., Leite M.L., Musicco M., Molinari S., and Lazzarin A. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The North Italian Seronegative Drug Addicts (NISDA) Study. Am. J. Epidemiol. 135 (1992) 225-233
31. Padian N.S., O'Brien T.R., Chang Y.C., Glass S., and Francis D.P. Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J. Acquir. Immune Defic. Syndr. 6 (1993) 1043-1048
32. Prendergast M.L., Urada D., and Podus D.J. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. Consult. Clin. Psychol. 69 (2001) 389-405
33. Seddon G.M. The properties of Bloom's taxonomy of educational objectives or the cognitive domain. Rev. Educ. Res. 48 (1978) 303-323
34. Semaan S., Des Jarlais D.C., Sogolow E., Johnson W.D., Hedges L.V., Ramirez G., Flores S.A., Norman L., Sweat M.D., and Needle R. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J. Acquir. Immune Defic. Syndr. 30 Suppl. 1 (2002) S73-S93
35. Sikkema K.J., Kelly J.A., Winett R.A., Solomon L.J., Cargill V.A., Roffman R.A., McAuliffe T.L., Heckman T.G., Anderson E.A., Wagstaff D.A., Norman A.D., Perry M.J., Crumble D.A., and Mercer M.B. Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low-income housing developments. Am. J. Pub. Health 90 (2000) 57-63
36. Strathdee S.A., and Sherman S.G. The role of sexual transmission of HIV infection among injection and non-injection drug users. J. Urban Health 80 (2003) iii7-iii14
37. The DUIT Study Team. Reduction in injection risk behaviors for HIV and HCV infection among young injection drug users using a peer-education intervention, submitted for publication.
38. Garfein R.S., Swartzendruber A., Ouellet L.J., Kapadia F., Hudson S.M., Thiede H., Strathdee S.A., Williams I.T., Bailey S.L., Hagan H., Golub E.T., Kerndt P., Hanson D.L., Latka M.H., and for the DUIT Study Team. Methods to recruit and retain a cohort of young adult injection drug users for the third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 91 Suppl. 1 (2007) S4-S17
39. Thomas D.L., Vlahov D., Solomon L., Cohn S., Taylor E., Garfein R., and Nelson K.E. Correlates of hepatitis C virus infection among injection drug users. Medicine (Baltimore) 74 (1995) 212-220
40. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., Monterroso E.R., and Garfein R.S. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 155 (2002) 645-653
41. Tucker T., Fry C.L., Lintzeris N., Baldwin S., Ritter A., Donath S., and Whelan G. Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users. Addiction 99 (2004) 1157-1166
42. van Ameijden E.J., van den Hoek J.A., van Haastrecht H.J., and Coutinho R.A. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injection drug users, Amsterdam. Am. J. Epidemiol. 136 (1992) 236-243
43. Villano S.A., Vlahov D., Nelson K.E., Lyles C.M., Cohn S., and Thomas D.L. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J. Clin. Microbiol. 35 (1997) 3274-3277
44. Wiebel W.W. Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model. In: Battjes R.J., and Pickens R.W. (Eds). Needle Sharing among Intravenous Drug Abusers: National and International Perspectives. NIDA Research Monograph 80 (1988), U.S. Government Printing Office, Washington, DC 137-150
45. Wolitski R.J., et al. Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men. AIDS 19 Suppl. (2005) S99-S109